Evidence map›Paper›PMID 38952278›Full record

ArticleVeterinary medicine and science2024

Pharmacokinetics, bioavailability and plasma protein binding of tolfenamic acid in rainbow trout (Oncorhynchus mykiss).

Orhan Corum, Duygu Durna Corum, Pedro Marin, Omer Faruk Acar, Mert Aksoy, Kamil Uney

Abstract read
In one paragraph

Article in Veterinary medicine and science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Orhan CorumDepartment of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Hatay Mustafa Kemal, Hatay, Turkiye.ORCID 0000-0003-3168-2510
Duygu Durna CorumDepartment of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Hatay Mustafa Kemal, Hatay, Turkiye.ORCID 0000-0003-1567-991X
Pedro MarinDepartment of Pharmacology, Faculty of Veterinary Medicine, University of Murcia, Murcia, Spain.ORCID 0000-0003-4849-4452
Omer Faruk AcarFaculty of Veterinary Medicine, University of Kastamonu, Kastamonu, Turkiye.
Mert AksoyFaculty of Veterinary Medicine, University of Kastamonu, Kastamonu, Turkiye.
Kamil UneyDepartment of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Selcuk, Konya, Turkiye.ORCID 0000-0002-8674-4873

Funding

The Scientific and Technological Research Council of Turkiye 1919B012108881The Scientific and Technological Research Council of Turkiye 2209-A
6 · The paper itself

Abstract

backgroundAlthough research on the mechanism and control of pain and inflammation in fish has increased in recent years, the use of analgesic drugs is limited due to the lack of pharmacological information about analgesic drugs. Tolfenamic acid is a non-steroidal anti-inflammatory drug and can be used in fish due to its low side effect profile and superior pharmacokinetic properties.

objectivesThe pharmacokinetics, bioavailability and plasma protein binding of tolfenamic acid were investigated following single intravascular (IV), intramuscular (IM) and oral administration of 2 mg/kg in rainbow trout at 13 ± 0.5°C.

methodsThe experiment was carried out on a total of 234 rainbow trout (Oncorhynchus mykiss). Tolfenamic acid was administered to fish via IV, IM and oral route at a dose of 2 mg/kg. Blood samples were taken at 13 different sampling times until the 72 h after drug administration. The plasma concentrations of tolfenamic acid were quantified using high pressure liquid chromatography-ultraviolet (UV) and pharmacokinetic parameters were assessed using non-compartmental analysis.

resultsThe elimination half-life (t

conclusionsWhile IM route, which exhibits both the high plasma concentration and bioavailability, can be used in rainbow trout, oral route is not recommended due to low plasma concentration and bioavailability. However, there is a need to demonstrate the pharmacodynamic activity of tolfenamic acid in rainbow trout.

Indexed as

Anti-Inflammatory Agents, Non-SteroidalBiological AvailabilityBlood ProteinsOncorhynchus mykissortho-AminobenzoatesAdministration, OralAnimalsHalf-LifeInjections, IntramuscularInjections, IntravenousProtein BindingAnti-Inflammatory Agents, Non-SteroidalBlood Proteinsortho-Aminobenzoatestolfenamic acidbioavailabilitypharmacokineticsplasma protein bindingrainbow trouttolfenamic acid

Identifiers

PMID38952278
PMCPMC11217592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.